Home » Topics » Regulatory » Patents

Patents
RSS

TME Therapeutics discovers PIKfyve inhibitors

May 19, 2022

CXCR4-targeting compounds patented by the University of British Columbia, PHSA

May 19, 2022

New KRAS protein degraders synthesized at BioTheryX

May 19, 2022

Celgene, Zoetis describe new compounds for treating helminthic infections

May 19, 2022

Mission Therapeutics patents USP30 inhibitors

May 18, 2022

Evotec International discovers integrated stress response pathway modulators

May 18, 2022

University of Ljubljana presents dual TLR7/NOD2 agonists

May 18, 2022

Palacky University describes neuroprotective cholestane derivatives

May 18, 2022

ILDONG Pharmaceutical synthesizes new CFTR modulators and/or PDE4 inhibitors

May 18, 2022

New non-receptor tyrosine-protein kinase TYK2 inhibitors described by PharmaBlock Sciences

May 17, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...